ADAM17 and myocardial infarction: After inhibiting P38MAPK activity, the expression of ADAM17 was significantly decreased and the remodeling of MI cardiomyocytes was alleviated, indicating that P38MAPK could regulate ADAM17 and participate in the pathogenic process of MI cardiomyocytes.